TERF2 gene expression in childhood acute lymphoblastic leukaemia / Lelamekala Vengidasan
Advances in the understanding of cell biology in childhood acute lymphoblastic leukemia (cALL) have led to sophisticated risk-stratification based therapeutic interventions targeting individual patients. Despite these advances, approximately 10-20% of children with ALL still relapse. Thus, identific...
| Auteur principal: | |
|---|---|
| Format: | Thèse |
| Publié: |
2011
|
| Sujets: |